Hepatitis C virus RNA replication machinery

The **Hepatitis C virus RNA replication machinery** refers to a highly organized, membrane-associated complex of nonstructural viral proteins (primarily NS3, NS4A, NS4B, NS5A, and NS5B), together with essential viral RNA elements and host cell factors, that orchestrates the replication of the viral positive-strand RNA genome[1][2][4]. The core component is the NS5B protein, a virus-encoded RNA-dependent RNA polymerase that synthesizes both negative- and positive-strand RNA, enabling progeny virus production[2][4]. The replication complex assembles on endoplasmic reticulum-derived membranes that are heavily remodeled by viral proteins, forming “membranous webs” that shelter RNA synthesis from host defenses[1][4][5]. This machinery is the primary site of action for direct-acting antiviral drugs, which target key components such as NS5B (polymerase inhibitors), NS5A (replication complex assembly inhibitors), and NS3-4A (protease inhibitors), disrupting the life cycle of HCV and enabling clinical cure in most patients[2][4]. The replication machinery is central to HCV pathogenicity, is a validated therapeutic target, and interacts both with viral RNA sequences (cis-acting elements) and host proteins involved in RNA metabolism and membrane biogenesis[3].

Other names

HCV replication complexHCV RNA replicaseHCV nonstructural protein complexHepatitis C virus replicaseHCV RNA-dependent RNA polymerase complex

Inhibition of NS5B RNA-dependent RNA polymerase, preventing viral RNA synthesis; Inhibition of NS5A protein, disrupting viral RNA replication and assembly; Inhibition of NS3/4A protease, blocking polyprotein processing and replication complex assembly